GLR Partners’s Medpace MEDP Stock Holding History

GLR Partners’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.59M	Sell	3,000 -3	-0.1%	-$1.39K	0.74%	36
2026 Q1	$1.44M	Buy	+3,003	New	+$1.54M	0.79%	37

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

GLR Partners's MEDP Position: Q2 2026 in Review

GLR Partners reduced its Medpace (MEDP) stake by 0.1% in Q2 2026, selling an estimated $1.39K and leaving 3,000 shares worth $1.59M. The position accounts for 0.74% of the portfolio, ranked #36.

GLR Partners first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

GLR Partners held 3,000 shares of Medpace worth $1.59M as of Q2 2026.
GLR Partners sold 3 Medpace shares in Q2 2026, an estimated $1.39K.
Medpace made up 0.74% of GLR Partners's portfolio in Q2 2026, its #36 holding.
GLR Partners first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on GLR Partners's 13F filing for Q2 2026, filed 27 Jul 2026.